Tags

Type your tag names separated by a space and hit enter

Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas.
Pancreas 2010; 39(3):340-4P

Abstract

OBJECTIVES

The objective of this study was to evaluate the efficacy of a pancreatic stent regarding the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms.

METHODS

A retrospective study was made to assess the outcome in 121 consecutive patients with intraductal papillary mucinous neoplasms who underwent endoscopic aspiration of pure pancreatic juice for cytologic examination between July 2001 and October 2007. From July 2001 to March 2004, 58 patients did not undergo pancreatic stent insertion (the no-stent [nS] group). The remaining 63 patients did undergo stent insertion (stent [S] group).

RESULTS

The overall incidences of post-ERCP pancreatitis was 11 (9.1%). The incidences of post-ERCP pancreatitis in the S and nS groups were 8 (12.7%) and 3 (5.2%; P = 0.21), respectively. In the male patients and the patients with a smaller diameter of the main pancreatic ducts, post-ERCP pancreatitis was seen more frequently in those in the S group (13% and 21%, respectively) than in those in the nS group (0% and 0%, respectively; P = 0.04, 0.03).

CONCLUSIONS

The pancreatic stent did not seem to decrease the incidence of post-ERCP pancreatitis in patients with intraductal papillary mucinous neoplasms. Furthermore, the pancreatic stent seems to be potentially detrimental in male patients and in patients with small-diameter main pancreatic ducts.

Authors+Show Affiliations

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Kurashiki Central Hospital, Okayama 700-8558, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19823100

Citation

Harada, Ryo, et al. "Nonprevention of Post-endoscopic Retrograde Cholangiopancreatographic Pancreatitis By Pancreatic Stent After Aspiration of Pure Pancreatic Juice in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas." Pancreas, vol. 39, no. 3, 2010, pp. 340-4.
Harada R, Kawamoto H, Fukatsu H, et al. Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2010;39(3):340-4.
Harada, R., Kawamoto, H., Fukatsu, H., Kato, H., Hirao, K., Kurihara, N., ... Yamamoto, H. (2010). Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreas, 39(3), pp. 340-4. doi:10.1097/MPA.0b013e3181bb8da1.
Harada R, et al. Nonprevention of Post-endoscopic Retrograde Cholangiopancreatographic Pancreatitis By Pancreatic Stent After Aspiration of Pure Pancreatic Juice in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 2010;39(3):340-4. PubMed PMID: 19823100.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas. AU - Harada,Ryo, AU - Kawamoto,Hirofumi, AU - Fukatsu,Hirotoshi, AU - Kato,Hironari, AU - Hirao,Ken, AU - Kurihara,Naoko, AU - Mizuno,Osamu, AU - Ogawa,Tsuneyoshi, AU - Ishida,Etsuji, AU - Okada,Hiroyuki, AU - Yamamoto,Kazuhide, AU - Yamamoto,Hiroshi, PY - 2009/10/14/entrez PY - 2009/10/14/pubmed PY - 2010/7/9/medline SP - 340 EP - 4 JF - Pancreas JO - Pancreas VL - 39 IS - 3 N2 - OBJECTIVES: The objective of this study was to evaluate the efficacy of a pancreatic stent regarding the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms. METHODS: A retrospective study was made to assess the outcome in 121 consecutive patients with intraductal papillary mucinous neoplasms who underwent endoscopic aspiration of pure pancreatic juice for cytologic examination between July 2001 and October 2007. From July 2001 to March 2004, 58 patients did not undergo pancreatic stent insertion (the no-stent [nS] group). The remaining 63 patients did undergo stent insertion (stent [S] group). RESULTS: The overall incidences of post-ERCP pancreatitis was 11 (9.1%). The incidences of post-ERCP pancreatitis in the S and nS groups were 8 (12.7%) and 3 (5.2%; P = 0.21), respectively. In the male patients and the patients with a smaller diameter of the main pancreatic ducts, post-ERCP pancreatitis was seen more frequently in those in the S group (13% and 21%, respectively) than in those in the nS group (0% and 0%, respectively; P = 0.04, 0.03). CONCLUSIONS: The pancreatic stent did not seem to decrease the incidence of post-ERCP pancreatitis in patients with intraductal papillary mucinous neoplasms. Furthermore, the pancreatic stent seems to be potentially detrimental in male patients and in patients with small-diameter main pancreatic ducts. SN - 1536-4828 UR - https://www.unboundmedicine.com/medline/citation/19823100/Nonprevention_of_post_endoscopic_retrograde_cholangiopancreatographic_pancreatitis_by_pancreatic_stent_after_aspiration_of_pure_pancreatic_juice_in_patients_with_intraductal_papillary_mucinous_neoplasms_of_the_pancreas_ L2 - http://dx.doi.org/10.1097/MPA.0b013e3181bb8da1 DB - PRIME DP - Unbound Medicine ER -